By Mr Deshan Frank Sebaratnam

Book Chapters

Phan K; O' Connor A; Sebaratnam D, 2020, 'Dermatological Emergencies', in Fulde G; Fulde S (ed.), Emergency Medicine The Principles of Practice, Elsevier, https://www.elsevier.com/books/emergency-medicine/fulde/978-0-7295-4301-9

Sebaratnam DF; Woodley DT; Murrell DF, 2015, 'Clinical Features of Bullous Systemic Lupus Erythematosus', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 413 - 418, http://dx.doi.org/10.1007/978-3-662-45698-9_41

Sebaratnam DF; Hertl M; Werth VP; Murrell D, 2015, 'Extent Measures in Autoimmune Bullous Disease', in Blistering Diseases: Clinical Features, Pathogenesis, Treatment, Springer Link, pp. 633 - 642, http://dx.doi.org/10.1007/978-3-662-45698-9_68

Murrell D; Werth V, 2011, 'Treatment of Pemphigus.', in Evidence Based Dermatology, People’s Medical Publishing House, pp. 261 - 277

Journal articles

Pham JP; Sebaratnam DF, 2024, 'Cost-utility and actionability of genomic sequencing for inflammatory linear verrucous epidermal nevus', Journal of the American Academy of Dermatology, 91, pp. e163 - e164, http://dx.doi.org/10.1016/j.jaad.2024.06.080

Li GX; Sebaratnam DF, 2024, 'Cost-utility of sirolimus in the treatment of vascular malformations', Australasian Journal of Dermatology, 65, pp. e259 - e262, http://dx.doi.org/10.1111/ajd.14369

Gu Y; de Silva D; Henderson CJA; Sebaratnam DF, 2024, 'Pembrolizumab-induced acquired perforating dermatosis', JEADV Clinical Practice, 3, pp. 1611 - 1614, http://dx.doi.org/10.1002/jvc2.462

Gu Y; Sebaratnam DF, 2024, 'Sonography of focal facial dermal dysplasia', Sonography, 11, pp. 375 - 377, http://dx.doi.org/10.1002/sono.12410

Chen MKY; Tatian A; Sebaratnam DF, 2024, 'Estimating Costs in Beremagene Geperpavec for Dystrophic Epidermolysis Bullosa', JAMA Dermatology, 160, http://dx.doi.org/10.1001/jamadermatol.2024.2999

Sebaratnam DF, 2024, 'Rook’s Textbook of Dermatology, 4 volume set, 10th edition', British Journal of Dermatology, 191, pp. 854 - 854, http://dx.doi.org/10.1093/bjd/ljae320

Gu Y; Truong K; Kossard S; Lim A; Sebaratnam DF, 2024, 'Eccrine angiomatous hamartoma treated with multimodal vascular laser and incobotulinum', Skin Health and Disease, 4, http://dx.doi.org/10.1002/ski2.434

Gu Y; Verheyden MJ; Sebaratnam DF; Liu RC, 2024, 'A Systematic Review of Laser Treatment for Angiofibromas in Tuberous Sclerosis', Dermatologic Surgery, 50, pp. 840 - 846, http://dx.doi.org/10.1097/DSS.0000000000004222

Chen MKY; Sebaratnam D, 2024, 'Ironing out the wrinkles: Navigating intrusive patient enquiries', Journal of the American Academy of Dermatology, 91, pp. 616 - 617, http://dx.doi.org/10.1016/j.jaad.2023.08.041

Li GX; Tantsis E; Sebaratnam DF, 2024, 'Facial birthmark, epilepsy and glaucoma in the infant', Journal of Paediatrics and Child Health, 60, pp. 387, http://dx.doi.org/10.1111/jpc.16606

Gu Y; Shih STF; Geevasinga N; Chan L; Frew JW; Sebaratnam DF, 2024, 'Economic Evaluation of HLA-B*15:02 Genotyping for Asian Australian Patients with Epilepsy', JAMA Dermatology, 160, pp. 631 - 640, http://dx.doi.org/10.1001/jamadermatol.2024.1037

Gu Y; Pham JP; Sebaratnam DF, 2024, 'Towards precision medicine in vascular anomalies: Could protein kinase C inhibitors be repurposed for GNAQ/11-related phakomatoses?', Skin Research and Technology, 30, http://dx.doi.org/10.1111/srt.13736

Gu Y; Sebaratnam DF, 2024, 'GLP-1 receptor agonists for hidradenitis suppurativa: Navigating benefits, risks, and ethical considerations', International Journal of Dermatology, 63, pp. e100 - e101, http://dx.doi.org/10.1111/ijd.17108

Ireland PA; Jansson N; Spencer SKR; Braden J; Sebaratnam D, 2024, 'Short-Term Cardiovascular Complications in Dermatology Patients Receiving JAK-STAT Inhibitors: A Meta-Analysis of Randomized Clinical Trials', JAMA Dermatology, 160, pp. 281 - 289, http://dx.doi.org/10.1001/jamadermatol.2023.5509

Gu Y; Frank Sebaratnam D, 2024, 'Adjuvant Topical Sirolimus for Pulsed Dye Laser in Pediatric Capillary Malformation', Dermatologic Surgery, 50, pp. 300 - 301, http://dx.doi.org/10.1097/DSS.0000000000004047

Chen MKY; Flanagan AL; Sebaratnam DF; Gu Y, 2024, 'Biologics for inherited disorders of keratinisation: A systematic review', Australasian Journal of Dermatology, 65, pp. 185 - 214, http://dx.doi.org/10.1111/ajd.14197

Gu Y; Tang GT; Cheung ASZ; Sebaratnam DF, 2024, 'Dermatological considerations for transgender and gender diverse patients: An Australian perspective', Australasian Journal of Dermatology, 65, pp. 24 - 36, http://dx.doi.org/10.1111/ajd.14179

Li GX; Sebaratnam DF, 2024, 'A resident with an orphan disease: Trial and error', Journal of the American Academy of Dermatology, http://dx.doi.org/10.1016/j.jaad.2024.04.063

Gu Y; Millan G; Sebaratnam DF, 2024, 'Arcanobacterium haemolyticum - Infection in an Immunocompetent Child', Pediatric Infectious Disease Journal, 43, pp. E28 - E29, http://dx.doi.org/10.1097/INF.0000000000004147

Gu Y; Shah KM; Li GX; Sebaratnam DF; Sun HY, 2024, 'Field therapies for actinic keratosis: an Australian cost-effectiveness analysis', JEADV Clinical Practice, http://dx.doi.org/10.1002/jvc2.564

Ireland PA; Verheyden M; Jansson N; Sebaratnam D; Sullivan J, 2024, 'Infection risk with JAK inhibitors in dermatoses: a meta-analysis', International Journal of Dermatology, http://dx.doi.org/10.1111/ijd.17501

Chen MKY; Sebaratnam DF, 2024, 'Light at the end of the tunnel: Laser in pediatric patients', Journal of the American Academy of Dermatology, http://dx.doi.org/10.1016/j.jaad.2024.09.005

Gu Y; Sebaratnam DF, 2024, 'Topical rapamycin and microcystic lymphatic malformations', Journal of the American Academy of Dermatology, 90, pp. e29 - e30, http://dx.doi.org/10.1016/j.jaad.2023.06.066

Gu Y; Shih S; Geevasinga N; Chan L; Frew J; Sebaratnam D, 2024, 'Economic evaluation of HLA-B*15:02 genotyping in Asian Australian epilepsy patients', Clinical Medicine, 24, pp. 100131 - 100131, http://dx.doi.org/10.1016/j.clinme.2024.100131

Gu Y; De Silva D; Henderson CJA; Sebaratnam DF, 2024, 'Pembrolizumab-induced acquired perforating dermatosis', Pathology, 56, pp. S58 - S58, http://dx.doi.org/10.1016/j.pathol.2023.12.198

Gu Y; Polcz MM; Sebaratnam DF, 2023, 'Multidisciplinary care of skin cancer in transplant recipients', Internal Medicine Journal, 53, pp. 2355 - 2356, http://dx.doi.org/10.1111/imj.16293

Gu Y; Sebaratnam DF, 2023, 'Contextualising associations of SJS/TEN with COVID-19 and the vaccine', Burns, 49, pp. 1776 - 1777, http://dx.doi.org/10.1016/j.burns.2023.08.003

Sun HY; Gu Y; Sebaratnam DF, 2023, 'Avoiding severe drug hypersensitivity reactions: a case for HLA genotyping for at-risk patients', Medical Journal of Australia, 219, pp. 285, http://dx.doi.org/10.5694/mja2.52065

Sebaratnam DF; Patel A; Lim A, 2023, 'Nonsurgical body contouring with energy devices', Medicine Today, 24, pp. 49 - 53

Sebaratnam DF; Lowe P; Lim A, 2023, 'Laser skin resurfacing: more than a cosmetic procedure', Medicine Today, 24, pp. 33 - 39, https://medicinetoday.com.au/mt/2023/august/regular-series/laser-skin-resurfacing-more-cosmetic-procedure

Wong XL; Farrell JA; Satchell AC; Sebaratnam DF, 2023, 'Teledermatology in the provision of biologics through COVID-19 in a rural dermatology practice—A retrospective review', Australasian Journal of Dermatology, 64, pp. e212 - e215, http://dx.doi.org/10.1111/ajd.14096

Kozera EK; Langan R; Singh-Grewal D; Sun HY; Sebaratnam DF; Henderson CJA, 2023, 'Neonatal lupus erythematosus presenting as a non-bullous histiocytoid neutrophilic dermatosis', Journal of Cutaneous Pathology, 50, pp. 524 - 529, http://dx.doi.org/10.1111/cup.14387

Farrell J; Hogan P; Sebaratnam DF, 2023, 'About PHACE', Journal of Pediatrics, 255, pp. 256 - 257, http://dx.doi.org/10.1016/j.jpeds.2022.10.024

Sun HY; Sebaratnam DF, 2023, 'Assessment of disutility in cost-effectiveness analyses in acne', Clinical and Experimental Dermatology, 48, pp. 242 - 243, http://dx.doi.org/10.1093/ced/llac066

Tjahjono R; Low HTH; Lee J; Sebaratnam DF; Gupta R; Veness MJ; Clark J; Palme CE, 2023, 'DANGER: what clinicians need to know about aggressive head and neck cutaneous squamous cell carcinoma', Medical Journal of Australia, 218, pp. 11 - 15, http://dx.doi.org/10.5694/mja2.51786

Wong XL; Sebaratnam D; Lowe PM, 2023, 'Cosmetic laser and light therapies', Medicine Today, 24, pp. 55 - 61, https://medicinetoday.com.au/mt/2023/may/regular-series/cosmetic-laser-and-light-therapies

Matos T; Godbole M; Grandy A; Demont E; Viti F; Bellinvia S; Zambeletti L; Sebaratnam D, 2023, 'EE563 Cost-Effectiveness of the PPARγ Modulator N-Acetyl-Ged-0507-34-Levo (NAC-GED 5%) Versus Benzoyl Peroxide-Adapalene for Moderate to Severe Acne', Value in Health, 26, pp. S161 - S161, http://dx.doi.org/10.1016/j.jval.2023.09.828

Foley P; Kerdraon YA; Hogden JP; Shumack S; Spelman L; Sebaratnam DF; Su CS; Katelaris CH, 2022, 'Dupilumab-associated ocular surface disease: An interdisciplinary decision framework for prescribers in the Australian setting', Australasian Journal of Dermatology, 63, pp. 421 - 436, http://dx.doi.org/10.1111/ajd.13924

Liang I; Hamid M; Sebaratnam D; Manolios N, 2022, 'The spectrum of cutaneous polyarteritis nodosa. A case report of two contrasting cases and review of the literature', CLINICAL CASE REPORTS, 10, http://dx.doi.org/10.1002/ccr3.6659

Flora A; Garg P; Cheung K; Sebaratnam DF; Gupta M, 2022, 'A polymorphic rash from across the seas', Medical Journal of Australia, 217, pp. 292 - 294, http://dx.doi.org/10.5694/mja2.51690

Chen MKY; Vissapragada R; Bulamu N; Gupta M; Werth V; Sebaratnam DF, 2022, 'Cost-Utility Analysis of Rituximab vs Mycophenolate Mofetil for the Treatment of Pemphigus Vulgaris', JAMA Dermatology, 158, pp. 1013 - 1021, http://dx.doi.org/10.1001/jamadermatol.2022.2878

Ricardo JW; Sun HY; Gorji M; Sebaratnam DF, 2022, 'Topical sodium thiosulfate as treatment of calcinosis cutis: Case series and systematic review', Journal of the American Academy of Dermatology, 87, pp. 443 - 444, http://dx.doi.org/10.1016/j.jaad.2021.09.013

Der Sarkissian S; Ge L; Sun HY; Chen MKY; Sebaratnam DF, 2022, 'Atenolol as treatment for hepatic hemangiomas in a premature infant', Pediatrics and Neonatology, 63, pp. 317 - 318, http://dx.doi.org/10.1016/j.pedneo.2021.12.002

Sun HY; Sebaratnam DF, 2022, 'Prurigo pigmentosa following a ketogenic diet: a case report', European Journal of Clinical Nutrition, 76, pp. 624 - 625, http://dx.doi.org/10.1038/s41430-021-00987-2

Chen MKY; Shen KT; Arulthasan SP; Sebaratnam DF, 2022, 'The spectre of visible difference: semiotics of disfigurement and moral character in James Bond films', Clinical and Experimental Dermatology, 47, pp. 767 - 768, http://dx.doi.org/10.1111/ced.15034

Sun HY; Phan K; Paller AS; Sebaratnam DF, 2022, 'Biologics for pediatric psoriasis: A systematic review and meta-analysis', Pediatric Dermatology, 39, pp. 42 - 48, http://dx.doi.org/10.1111/pde.14870

Back to profile page